ABBV logo

AbbVie (ABBV) Current Assets

Annual Current Assets

N/A

December 1, 2024


Summary


Performance

ABBV Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherABBVbalance sheetmetrics:

Quarterly Current Assets

N/A

December 1, 2024


Summary


Performance

ABBV Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherABBVbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

ABBV Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

ABBV Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

AbbVie Current Assets History

DateAnnualQuarterly
Sep 2024
-
$27.79 B(-17.8%)
Jun 2024
-
$33.82 B(-13.0%)
Mar 2024
-
$38.87 B(+17.8%)
Dec 2023
$101.71 B(-7.8%)
$33.00 B(-0.7%)
Sep 2023
-
$33.22 B(+15.2%)
Jun 2023
-
$28.85 B(+8.9%)
Mar 2023
-
$26.49 B(-6.9%)
Dec 2022
$110.34 B(-7.0%)
$28.46 B(-6.3%)
Sep 2022
-
$30.36 B(+4.3%)
Jun 2022
-
$29.10 B(+9.8%)
Mar 2022
-
$26.51 B(-5.1%)
Dec 2021
$118.60 B(-6.2%)
$27.93 B(-3.6%)
Sep 2021
-
$28.96 B(+11.4%)
Jun 2021
-
$26.00 B(-2.1%)
Mar 2021
-
$26.57 B(+9.9%)
Dec 2020
$126.39 B(+219.2%)
$24.17 B(+5.1%)
Sep 2020
-
$23.01 B(+8.2%)
Jun 2020
-
$21.26 B(-58.9%)
Mar 2020
-
$51.76 B(+4.5%)
Dec 2019
$39.60 B(-6.6%)
$49.52 B(+145.6%)
Sep 2019
-
$20.17 B(+33.5%)
Jun 2019
-
$15.10 B(+4.8%)
Mar 2019
-
$14.41 B(-14.9%)
Dec 2018
$42.41 B
$16.95 B(-8.2%)
Sep 2018
-
$18.46 B(+33.4%)
Jun 2018
-
$13.85 B(-32.3%)
DateAnnualQuarterly
Mar 2018
-
$20.44 B(-3.7%)
Dec 2017
$49.56 B(-0.7%)
$21.22 B(+12.1%)
Sep 2017
-
$18.93 B(+11.6%)
Jun 2017
-
$16.96 B(+9.1%)
Mar 2017
-
$15.55 B(-4.0%)
Dec 2016
$49.91 B(+35.9%)
$16.19 B(-0.6%)
Sep 2016
-
$16.29 B(-3.0%)
Jun 2016
-
$16.79 B(+1.0%)
Mar 2016
-
$16.62 B(+1.9%)
Dec 2015
$36.74 B(+221.3%)
$16.31 B(-8.9%)
Sep 2015
-
$17.91 B(+6.1%)
Jun 2015
-
$16.88 B(+9.5%)
Mar 2015
-
$15.41 B(-4.2%)
Dec 2014
$11.43 B(+0.7%)
$16.08 B(-8.4%)
Sep 2014
-
$17.55 B(-1.3%)
Jun 2014
-
$17.79 B(+2.7%)
Mar 2014
-
$17.33 B(-2.9%)
Dec 2013
$11.35 B(-2.6%)
$17.85 B(+7.9%)
Sep 2013
-
$16.54 B(+5.6%)
Jun 2013
-
$15.66 B(+5.0%)
Mar 2013
-
$14.92 B(-2.8%)
Dec 2012
$11.65 B(-4.2%)
$15.35 B(+40.5%)
Sep 2012
-
$10.93 B(+82.4%)
Jun 2012
-
$5.99 B(-11.2%)
Mar 2012
-
$6.75 B(-8.2%)
Dec 2011
$12.17 B(-5.8%)
$7.35 B
Dec 2010
$12.92 B
-

FAQ

  • What is the all time high annual current assets for AbbVie?
  • What is the all time high quarterly current assets for AbbVie?

What is the all time high annual current assets for AbbVie?

AbbVie all-time high annual total current assets is $49.52 B

What is the all time high quarterly current assets for AbbVie?

AbbVie all-time high quarterly total current assets is $51.76 B